Dorothee Riedlinger, Fabian Holert, Petra Gastmeier, Axel Kola, Anna Slagman, Vmd, Martin Möckel
{"title":"Risk factors for Staphylococcus aureus colonization in a general emergency department patient cohort - results of an observational cohort study.","authors":"Dorothee Riedlinger, Fabian Holert, Petra Gastmeier, Axel Kola, Anna Slagman, Vmd, Martin Möckel","doi":"10.1080/1354750X.2025.2451950","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Testing for <i>Staphylococcus aureus</i> (SA) colonization in emergency department (ED) patients may guide prevention strategies against hospital acquired infections (HAI). This study determined the prevalence of SA carriers in a general ED population, characterized the population, and identified predictors for SA colonization.</p><p><strong>Methods: </strong>A prospective monocentric observational cohort study in a tertiary care hospital collected nasopharyngeal swabs in 1,000 adult patients. PCR testing for methicillin resistant and methicillin sensitive SA (MRSA/MSSA) was performed. Risk factor questionnaires and routine data from the clinical information system were captured. Descriptive statistics and binary logistic regression models were applied to report prevalence and outcomes and to identify predictors.</p><p><strong>Results: </strong>The prevalence for SA was 33.7% (n = 328; 95%-CI: 30.7-36.8): MSSA 30.9% (n = 301; 95%-CI: 28.0-34.0) and MRSA 2.8% (n = 27; 95%-CI: 1.8-4.0). POC PCR testing in the ED was feasible. Key predictors of SA colonization included having a catheter (OR 2.0, 95%-CI 1.0-4.0, p = 0.044) and requiring nursing care (OR 1.9, 95%-CI: 1.2-2.9, p = 0.007), even after adjusting for age and sex.</p><p><strong>Conclusion: </strong>Testing strategies for SA detection in ED need to focus on vulnerable populations with an elevated risk for HAIs and associated adverse outcomes. Individuals requiring nursing care could be a key target population for screening efforts.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-14"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1354750X.2025.2451950","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Testing for Staphylococcus aureus (SA) colonization in emergency department (ED) patients may guide prevention strategies against hospital acquired infections (HAI). This study determined the prevalence of SA carriers in a general ED population, characterized the population, and identified predictors for SA colonization.
Methods: A prospective monocentric observational cohort study in a tertiary care hospital collected nasopharyngeal swabs in 1,000 adult patients. PCR testing for methicillin resistant and methicillin sensitive SA (MRSA/MSSA) was performed. Risk factor questionnaires and routine data from the clinical information system were captured. Descriptive statistics and binary logistic regression models were applied to report prevalence and outcomes and to identify predictors.
Results: The prevalence for SA was 33.7% (n = 328; 95%-CI: 30.7-36.8): MSSA 30.9% (n = 301; 95%-CI: 28.0-34.0) and MRSA 2.8% (n = 27; 95%-CI: 1.8-4.0). POC PCR testing in the ED was feasible. Key predictors of SA colonization included having a catheter (OR 2.0, 95%-CI 1.0-4.0, p = 0.044) and requiring nursing care (OR 1.9, 95%-CI: 1.2-2.9, p = 0.007), even after adjusting for age and sex.
Conclusion: Testing strategies for SA detection in ED need to focus on vulnerable populations with an elevated risk for HAIs and associated adverse outcomes. Individuals requiring nursing care could be a key target population for screening efforts.
期刊介绍:
The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.
Biomarkers provides a vital forum for the exchange of ideas and concepts in all areas of biomarker research. High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged:
• Biomarkers of disease
• Biomarkers of exposure
• Biomarkers of response
• Biomarkers of susceptibility
Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro. Biomarkers will consider publishing negative data from studies of biomarkers of susceptibility in human populations.